Characterization of the novel suramin analogue NF110 as a potent P2X3 receptor-selective antagonist

被引：0
|
作者：
Hausmann, R
Rettinger, J
Kassack, M
Lambrecht, G
Schmalzing, G
机构：
[1] Rhein Westfal TH Aachen, D-52074 Aachen, Germany
[2] Max Planck Inst Biophys, D-60439 Frankfurt, Germany
[3] Univ Bonn, Dept Pharmaceut Chem, D-53121 Bonn, Germany
[4] Univ Frankfurt, Dept Pharmacol, D-60439 Frankfurt, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2004年 / 369卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
111
引用
收藏
页码：R28 / R28
页数：1
相关论文
共 50 条
  • [21] Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers
    Davenport, Adam J.
    Neagoe, Ioana
    Braeuer, Nico
    Koch, Markus
    Rotgeri, Andrea
    Nagel, Jens
    Laux-Biehlmann, Alexis
    Machet, Frederic
    Coelho, Anne-Marie
    Boyce, Susan
    Carty, Nikisha
    Gemkow, Mark J.
    Hess, Stephen D.
    Zollner, Thomas M.
    Fischer, Oliver M.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [22] Identification and electrophysiological characterization of the suramin derivative NF770 as a selective antagonist of recombinant rat P2X2 receptors
    Wolf, C
    Hausmann, R
    Lambrecht, G
    Kassack, M
    Schmalzing, G
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 42 - 42
  • [23] Identification of aurintricarboxylic acid as a potent allosteric antagonist of P2X1 and P2X3 receptors
    Obrecht, Astrid S.
    Urban, Nicole
    Schaefer, Michael
    Roese, Anni
    Kless, Achim
    Meents, Jannis E.
    Lampert, Angelika
    Abdelrahman, Aliaa
    Mueller, Christa E.
    Schmalzing, Gunther
    Hausmann, Ralf
    NEUROPHARMACOLOGY, 2019, 158
  • [24] BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration
    Garceau, Denis
    Chauret, Nathalie
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2019, 56 : 56 - 62
  • [25] Identification and SAR of novel diaminopyrimidines. Part 2: The discovery of RO-51, a potent and selective, dual P2X3/P2X2/3 antagonist for the treatment of pain
    Jahangir, Alam
    Alam, Muzaffar
    Carter, David S.
    Dillon, Michael P.
    Du Bois, Daisy Joe
    Ford, Anthony P. D. W.
    Gever, Joel R.
    Lin, Clara
    Wagner, Paul J.
    Zhai, Yansheng
    Zira, Jeff
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (06) : 1632 - 1635
  • [26] Characterization of three diaminopyrimidines as potent and selective antagonists of P2X3 and P2X2/3 receptors with in vivo efficacy in a pain model
    Ballini, E.
    Virginio, C.
    Medhurst, S. J.
    Summerfield, S. G.
    Aldegheri, L.
    Buson, A.
    Carignani, C.
    Chen, Y. H.
    Giacometti, A.
    Lago, I.
    Powell, A. J.
    Jarolimek, W.
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (06) : 1315 - 1325
  • [27] Novel series P2X3 receptor antagonists: Discovery of potent and orally efficacious pyrrolinone derivatives
    Asahi, Kentaro
    Kameyama, Takayuki
    Horiguchi, Tohru
    Oohara, Miho
    Tada, Yukio
    Tobinaga, Hiroyuki
    Kurihara, Naoko
    Kanda, Yasuhiko
    Tomari, Maki
    Tanaka, Yoshikazu
    Takahashi, Fumiyo
    Yagi, Shigenori
    Shigetoshi, Emiko
    Takahara, Yukio
    Takeyama, Chie
    Tsuji, Hiroki
    Yamamoto, Shoichi
    Shinohara, Shunji
    Kai, Hiroyuki
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [28] Effects of A-317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration
    McGaraughty, S
    Wismer, CT
    Zhu, CZ
    Mikusa, J
    Honore, P
    Chu, KL
    Lee, CH
    Faltynek, CR
    Jarvis, MF
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (08) : 1381 - 1388
  • [29] Effects of Renal Impairment on the Pharmacokinetics of Gefapixant, a P2X3 Receptor Antagonist
    Nussbaum, Jesse C.
    Hussain, Azher
    Min, K. Chris
    Marbury, Thomas C.
    Lasseter, Kenneth
    Stoch, S. Aubrey
    Iwamoto, Marian
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (11): : 1435 - 1444
  • [30] Blockade and reversal of spinal morphine tolerance by P2X3 receptor antagonist
    Ma, Xiaqing
    Xu, Tao
    Xu, Hao
    Jiang, Wei
    BEHAVIOURAL PHARMACOLOGY, 2015, 26 (03): : 260 - 267
12345